Company profile for Cytoreason

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

With one of the world’s largest libraries of human molecular data, and a platform to make that data accessible and useful, CytoReason is able to turn data into actionable biological insights for use in clinical and pre-clinical drug development programs. CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients,...
With one of the world’s largest libraries of human molecular data, and a platform to make that data accessible and useful, CytoReason is able to turn data into actionable biological insights for use in clinical and pre-clinical drug development programs. CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients, at the right time.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
Floor 16, Round Building, Azrieli Center, Menachem Begin 132, Tel Aviv 67012
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240717912688/en

BUSINESSWIRE
17 Jul 2024

https://www.contractpharma.com/contents/view_breaking-news/2023-01-23/cytoreason-licenses-ibd-disease-model-to-sanofi-in-expanded-alliance/?widget=listSection

CONTRACT PHARMA
23 Jan 2023
CytoReason, Pfizer ink $110M extension of AI collab
CytoReason, Pfizer ink $110M extension of AI collab

21 Sep 2022

// Andrea Park FIERCEBIOTECH

https://www.fiercebiotech.com/medtech/cytoreason-pfizer-ink-110m-five-year-extension-ai-powered-drug-development-deal

Andrea Park FIERCEBIOTECH
21 Sep 2022

https://www.globenewswire.com/news-release/2022/09/20/2519131/0/en/CytoReason-Announces-Expanded-Collaboration-Deal-with-Pfizer-to-Deliver-AI-for-Drug-Discovery-and-Development.html

GLOBENEWSWIRE
20 Sep 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-09-20/cytoreason-extends-multi-year-partnership-with-pfizer/

CONTRACTPHARMA
20 Sep 2022
CytoReason expands reach in Asia
CytoReason expands reach in Asia

13 Apr 2022

// BIOSPECTRUMASIA

https://www.biospectrumasia.com/news/26/20077/cytoreason-expands-reach-in-asia-leveraging-ml-in-drug-development-for-korean-drugmakers-.html

BIOSPECTRUMASIA
13 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty